A systematic review and meta-analysis on endovascular treatment as an attractive alternative for acute superior mesenteric venous thrombosis

被引:3
|
作者
Wang, Lixin [1 ,2 ,3 ]
Wang, Enci [2 ,3 ]
Liu, Fei [2 ,3 ]
Zhang, Wei [2 ,3 ]
Shu, Xiaolong [2 ,3 ]
Guo, Daqiao [2 ,3 ]
Fu, Weiguo [1 ,2 ,3 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Xiamen Branch, Dept Vasc Surg, Xiamen, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Vasc Surg, Shanghai 200032, Peoples R China
[3] Fudan Univ, Vasc Surg Inst, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Superior mesenteric venous thrombosis; anticoagulation; conservative treatment; surgical treatment; endovascular therapy; VEIN-THROMBOSIS; THROMBOLYSIS; CATHETER; THERAPY;
D O I
10.1177/1708538121991270
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective This systematic review and meta-analysis evaluated the published data on the efficacy and safety of therapies for superior mesenteric venous thrombosis (SMVT), aiming to provide a reference and set of recommendations for clinical treatment. Methods Relevant databases were searched for studies published from 2000 to June 2020 on SMVT treated with conservative treatment, surgical treatment, or endovascular approach. Different treatment types were grouped for analysis and comparison, and odds ratios with corresponding 95% confidence intervals were calculated. The outcomes were pooled using meta-analytic methods and presented by forest plots. Results Eighteen articles, including eight on SMVT patients treated with endovascular therapies, were enrolled. The treatment effectiveness was compared between different groups according to the change of symptoms, the occurrence of complications, and mortality as well. The conservative treatment group had better efficacy compared to the surgery group (89.0% vs. 78.6%, P <0.05), and the one-year survival rate was also higher (94.4% vs. 80.0%, P >0.05), but without statistical significance. As for endovascular treatment, the effectiveness was significantly higher than the surgery group (94.8% vs. 75.2%, P <0.05), and the conservative treatment group as well (93.3% vs. 86.3%, P >0.05), which still requires further research for the lack of statistical significance. Conclusions Present findings indicate that anticoagulation, as conservative treatment should be the preferred clinical option in the clinic for SMVT, due to its better curative effect compared to other treatment options, including lower mortality, fewer complications, and better prognosis. Moreover, endovascular treatment is a feasible and promising approach that is worth in-depth research, for it is less invasive than surgery and has relatively better effectiveness, thus can provide an alternative option for SMVT treatment and may be considered as a reliable method in clinical.
引用
收藏
页码:331 / 340
页数:10
相关论文
共 50 条
  • [1] Systematic review and meta-analysis of endovascular treatment for acute mesenteric ischaemia
    El Farargy, Marawan
    Hadi, Ahmed Abdel
    Abou Eisha, Mohamed
    Bashaeb, Khalid
    Antoniou, George A.
    VASCULAR, 2017, 25 (04) : 430 - 438
  • [2] Transvenous Endovascular Recanalization for Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis
    Lewis, Whitfield
    Saber, Hamidreza
    Sadeghi, Mahsa
    Rajah, Gary
    Narayanan, Sandra
    WORLD NEUROSURGERY, 2019, 130 : 341 - 350
  • [3] A Systematic Review and Meta-Analysis of the Efficacy of Conservative versus Surgical Treatment for Superior Mesenteric Vein Thrombosis
    Tang, Liming
    Yu, Jieni
    Xu, Chao
    Ma, Yuliang
    Sun, Yifeng
    Wang, Guohua
    Liu, Chunjiang
    Jin, Gan
    Tang, Xiaoqi
    Zhan, Chuanchuan
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2024, 26 (01)
  • [4] Endovascular treatment of iliofemoral deep venous thrombosis: is there enough evidence to support it? A systematic review with meta-analysis
    Diniz, Joao
    Coelho, Andreia
    Mansilha, Armando
    INTERNATIONAL ANGIOLOGY, 2020, 39 (02) : 93 - 104
  • [5] ACUTE SUPERIOR MESENTERIC VENOUS THROMBOSIS - TREATMENT BY THROMBECTOMY
    INAHARA, T
    ANNALS OF SURGERY, 1971, 174 (06) : 956 - &
  • [6] Endovascular and Medical Management of Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis
    Naik, Anant
    Smith, Emily
    Dharnipragada, Rajiv
    Catapano, Joshua S.
    Cramer, Samuel W.
    Johnson, Ryan
    Khanam, Rukhsaar
    Hassaneen, Wael
    Lawton, Michael T.
    Arnold, Paul M.
    WORLD NEUROSURGERY, 2022, 165 : E197 - E205
  • [7] Superior Mesenteric Venous Thrombosis Outcomes and Endovascular Management
    Alnahhal, Khaled I.
    Farres, Houssam
    Nussbaum, Samuel
    Erben, Young
    Hakaim, Albert
    Toskich, Beau
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (01) : E160 - E160
  • [8] Superior mesenteric venous thrombosis: Endovascular management and outcomes
    Alnahhal, Khaled
    Toskich, Beau B.
    Nussbaum, Samuel
    Li, Zhuo
    Erben, Young
    Hakaim, Albert G.
    Farres, Houssam
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (01) : 217 - 226
  • [9] Superior mesenteric venous thrombosis: Endovascular management and outcomes
    Khaled Alnahhal
    Beau B Toskich
    Samuel Nussbaum
    Zhuo Li
    Young Erben
    Albert G Hakaim
    Houssam Farres
    World Journal of Clinical Cases, 2022, (01) : 217 - 226
  • [10] Recanalization in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis
    de Sousa, Diana Aguiar
    Lucas Neto, Lia
    Canhao, Patricia
    Ferro, Jose M.
    STROKE, 2018, 49 (08) : 1828 - 1835